Search

everythinglearnresearchcommunity

for

Search:↓

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Adipose-derived stem cells show promise for hair growth but need improvement for clinical use.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Higher hair follicle density leads to more wool in rabbits, influenced by specific genes and lncRNAs.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Melatonin affects gene expression in goat hair follicles, potentially increasing cashmere production.

Stress hormone corticosterone suppresses hair growth by affecting stem cell activity and Gas6 protein expression.

Clonally expanded CD8+ T cells cause alopecia areata.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Blood metabolites significantly influence alopecia areata risk.